Identification, isolation and characterization of a new degradation product in sultamicillin drug substance

J Pharm Biomed Anal. 2011 Feb 20;54(3):582-7. doi: 10.1016/j.jpba.2010.09.016. Epub 2010 Sep 19.

Abstract

A new degradant of sultamicillin drug substance was found during the gradient reverse phase HPLC analysis of stability storage samples. The level of this degradant impurity was observed up to 1.0%. The impurity (formaldehyde adduct with 5-oxo-4-phenylimidazolidin-1-yl moiety) was identified by LC/MS and was characterized by ((1)H NMR, (13)C NMR, 2D-NMR ((1)H-(1)H COSY, NOESY, HSQC and HMBC), LC/MS/MS, MS/TOF, elemental analysis and IR. This impurity was prepared by isolation and co-injected into HPLC system to confirm the retention time.

MeSH terms

  • Ampicillin / analysis
  • Ampicillin / chemistry
  • Ampicillin / pharmacology
  • Chromatography, High Pressure Liquid
  • Chromatography, Liquid
  • Drug Contamination*
  • Drug Stability
  • Humans
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Pneumonia / drug therapy*
  • Spectrophotometry, Infrared
  • Sulbactam / analysis
  • Sulbactam / chemistry
  • Sulbactam / pharmacology
  • Tandem Mass Spectrometry

Substances

  • sultamicillin
  • Ampicillin
  • Sulbactam